Diamedica Therapeutics Stock Price on November 27, 2024

DMAC Stock  USD 5.21  0.13  2.56%   
Below is the normalized historical share price chart for DiaMedica Therapeutics extending back to January 04, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DiaMedica Therapeutics stands at 5.21, as last reported on the 28th of November, with the highest price reaching 5.56 and the lowest price hitting 5.07 during the day.
IPO Date
4th of January 2008
200 Day MA
3.3922
50 Day MA
4.292
Beta
1.456
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in DiaMedica Stock, it is important to understand the factors that can impact its price. DiaMedica Therapeutics appears to be slightly risky, given 3 months investment horizon. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15% return per unit of standard deviation over the last 3 months. By reviewing DiaMedica Therapeutics' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please utilize DiaMedica Therapeutics' Mean Deviation of 2.47, downside deviation of 2.33, and Semi Deviation of 2.08 to check if our risk estimates are consistent with your expectations.
  
At present, DiaMedica Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 56.9 M, whereas Stock Based Compensation is forecasted to decline to about 876.3 K. . As of November 28, 2024, Price To Sales Ratio is expected to decline to 49.24. In addition to that, Price Earnings Ratio is expected to decline to -5.01. DiaMedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1515

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsDMAC
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.31
  actual daily
29
71% of assets are more volatile

Expected Return

 0.5
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.15
  actual daily
11
89% of assets perform better
Based on monthly moving average DiaMedica Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DiaMedica Therapeutics by adding it to a well-diversified portfolio.
Price Book
4.1188
Book Value
1.345
Enterprise Value
147.7 M
Enterprise Value Ebitda
(0.96)
Shares Float
26.3 M

DiaMedica Therapeutics Valuation on November 27, 2024

It is possible to determine the worth of DiaMedica Therapeutics on a given historical date. On November 27, 2024 DiaMedica was worth 5.08 at the beginning of the trading date compared to the closed value of 5.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of DiaMedica Therapeutics stock. Still, in general, we apply an absolute valuation method to find DiaMedica Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of DiaMedica Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against DiaMedica Therapeutics' related companies.
 Open High Low Close Volume
  4.68    5.14    4.68    5.08    175,509  
11/27/2024
  5.08    5.56    5.07    5.21    195,488  
Backtest DiaMedica Therapeutics  |  DiaMedica Therapeutics History  |  DiaMedica Therapeutics Valuation   Previous
Open Value
5.08
5.21
Closing Value
15.00
Upside

DiaMedica Therapeutics Trading Date Momentum on November 27, 2024

On November 27 2024 DiaMedica Therapeutics was traded for  5.21  at the closing time. The top price for the day was 5.56  and the lowest listed price was  5.07 . The trading volume for the day was 195.5 K. The trading history from November 27, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.50% .

DiaMedica Therapeutics Fundamentals Correlations and Trends

By evaluating DiaMedica Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among DiaMedica Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. DiaMedica financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About DiaMedica Therapeutics Stock history

DiaMedica Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DiaMedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DiaMedica Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DiaMedica Therapeutics stock prices may prove useful in developing a viable investing in DiaMedica Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding32.6 M34.2 M
Net Loss-12.2 M-11.6 M

DiaMedica Therapeutics Quarterly Net Working Capital

46.47 Million

DiaMedica Therapeutics Stock Technical Analysis

DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DiaMedica Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DiaMedica Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

DiaMedica Therapeutics Period Price Range

Low
November 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

DiaMedica Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

DiaMedica Therapeutics November 28, 2024 Market Strength

Market strength indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By undertsting and applying DiaMedica Therapeutics stock market strength indicators, traders can identify DiaMedica Therapeutics entry and exit signals to maximize returns

DiaMedica Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for DiaMedica Therapeutics' price direction in advance. Along with the technical and fundamental analysis of DiaMedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DiaMedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for DiaMedica Stock analysis

When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Volatility Analysis
Get historical volatility and risk analysis based on latest market data